Michael A Shearer

Title: Innovator Spotlight: Michael A. Shearer

Introduction

Michael A. Shearer, based in Fairfield, California, is an accomplished inventor with a focus on pharmaceutical innovations. With a track record of three patents, his contributions to drug formulation and delivery methods are noteworthy.

Latest Patents

Among his latest patents, Shearer developed a formulation for a stabilized interleukin-2 that comprises human interleukin-2 or its variants, along with key stabilizing agents like histidine. This formulation notably includes a combination of glycine and sucrose, achieving a lyophilized form that, upon reconstitution with an aqueous diluent, results in a solution with a pH between 5.0 and 6.5. Another significant patent involves compositions for nasal drug delivery, especially aimed at antiviral agents. His work in this area includes methods for producing these compositions and improving the removal of residual solvents from pharmaceutical preparations.

Career Highlights

Throughout his career, Michael A. Shearer has collaborated with renowned organizations such as Bayer Corporation and Bayer Pharmaceuticals Corporation. His tenure at these leading companies has solidified his reputation as a pioneer in the field of pharmaceutical sciences.

Collaborations

Shearer has had the opportunity to work alongside esteemed colleagues, including Rajiv Nayar and Wei Wang. Their collaboration has likely contributed to the advancement of drug delivery systems and pharmaceutical formulations.

Conclusion

Michael A. Shearer exemplifies the innovative spirit essential to the pharmaceutical industry. His advancements in drug formulations and nasal delivery systems continue to influence modern medicine, positioning him as a key figure in pharmaceutical innovation.